Your browser doesn't support javascript.
loading
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets.
Mori, Minako; Kubota, Yasuo; Durmaz, Arda; Gurnari, Carmelo; Goodings, Charnise; Adema, Vera; Ponvilawan, Ben; Bahaj, Waled S; Kewan, Tariq; LaFramboise, Thomas; Meggendorfer, Manja; Haferlach, Claudia; Barnard, John; Wlodarski, Marcin; Visconte, Valeria; Haferlach, Torsten; Maciejewski, Jaroslaw P.
Afiliação
  • Mori M; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Kubota Y; Department of Hematology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Durmaz A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Goodings C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Adema V; Department of Biomedicine and Prevention, Ph.D. in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
  • Ponvilawan B; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Bahaj WS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kewan T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • LaFramboise T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Meggendorfer M; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Haferlach C; Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Barnard J; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Wlodarski M; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Visconte V; Department of Quantitative Health Sciences, Cleveland Clinic, Lerner Research Institute, Cleveland, OH, USA.
  • Haferlach T; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Leukemia ; 37(10): 2082-2093, 2023 10.
Article em En | MEDLINE | ID: mdl-37634012
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article